Recently, CAR-T cells targeting PD-L1 were shown to be effective in suppressing tumor growth of human xenograft models of HCC, nonetheless CAR PD-L1 T cells might recognize and kill normal cells expressing PD-L1 and therefore its safety needs to evaluated before clinical application [153]. This evidence concerns the gene CD274 and hepatocellular carcinoma.